After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Dynavax Technologies Corp is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Dynavax Technologies Corp is $1.14B. A total of 1.33 million shares were traded on the day, compared to an average of 1.72M shares.
In the most recent transaction, Myers Scott Dunseth bought 3,800 shares of DVAX for 10.82 per share on Aug 22 ’25. After the transaction, the Director now owns 35,004 company shares. In a previous transaction on Aug 21 ’25, Deep Track Biotechnology Maste sold 1,094,994 shares at 11.03 per share. DVAX shares that 10% Owner owns now total 16,696,492.
Among the insiders who sold shares, Deep Track Biotechnology Maste disposed of 970,143 shares on Aug 22 ’25 at a per-share price of $10.59. This resulted in the 10% Owner holding 15,726,349 shares of DVAX after the transaction. In another insider transaction, Novack David F sold 10,000 shares at $14.00 per share on Mar 24 ’25. Company shares held by the President & COO now total 8,078.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DVAX has a high of $14.63 and a low of $9.20.
As of this writing, DVAX has an earnings estimate of $0.12 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.15 per share and a lower estimate of $0.09. The company reported an EPS of $0.12 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DVAX’s latest balance sheet shows that the firm has $545.95M in Cash & Short Term Investments as of fiscal 2021. There were $257.38M in debt and $556.40M in liabilities at the time. Its Book Value Per Share was $4.22, while its Total Shareholder’s Equity was $222.37M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DVAX is Buy with a score of 3.80.
